1. Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy
   Mariarosaria Conte et al, 2020, Marine Drugs CrossRef
2. Clear cell sarcoma: state-of-the art and perspectives
   Laureline Wetterwald et al, 2023, Expert Review of Anticancer Therapy CrossRef
3. 当科における進行軟部肉腫に対するエリブリンの使用経験
   悠太 久保田 et al, 2022, Orthopedics & Traumatology CrossRef
4. Mesenchymal Stem Cells and Sarcoma
   J. Hatina et al, 2024, Reference Module in Biomedical Sciences CrossRef
5. Safety and effectiveness of eribulin in Japanese patients with soft tissue sarcoma including rare subtypes: a post-marketing observational study
   Akira Kawai et al, 2022, BMC Cancer CrossRef